News archive
| 2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 |
- 02-09-2010
Pfizer To Acquire FoldRx Pharmaceuticals - 01-09-2010
Archimedes Pharma Receives European Marketing Authorisation for PecFent® for the Treatment of Breakthrough Cancer Pain - 01-09-2010
Otonomy Closes $38.5 Million Series B Financing - 30-08-2010
LifeCycle Pharma announces Shionogi Pharma terminates Fenoglide® North American commercialization agreement - 30-08-2010
Epitherapeutics extends seed financing round, OSI Pharmaceuticals Inc. joins Syndicate - 26-08-2010
Novo A/S increases its shareholding in Orexo AB - 24-08-2010
Archimedes Pharma US announces new US headquarters in Bedminster, New Jersey - 24-08-2010
Orexo AB (STO: ORX) launches its next strategic steps and announces interim results for January-June 2010 - 23-08-2010
Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402 - 12-08-2010
LifeCycle Pharma Receives Special Protocol Assessment (SPA) from FDA for LCP-Tacro™ Pivotal Phase 3 Study in De Novo Kidney Transplant Patients
| Page 1 of 8 | » Next page |